VanEck Biotech ETF (BBH)
NASDAQ: BBH · Real-Time Price · USD
234.14
-2.58 (-1.09%)
At close: Sep 18, 2026, 4:00 PM EDT
234.26
+0.12 (0.05%)
After-hours: Sep 18, 2026, 7:30 PM EDT
BBH Holdings Information
BBH is an equity ETF with a total of 25 individual holdings. The top holdings are Amgen stock at 13.74%, Gilead Sciences at 13.12%, Vertex Pharmaceuticals at 8.13%, Regeneron Pharmaceuticals at 6.76%, and Moderna at 6.52%.
Total Holdings
25
Top 10 Percentage
72.30%
Asset Class
Equity
ETF Category
Health
Assets
463.89M
PE Ratio
26.62
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | AMGN | Amgen Inc. | 13.74% |
| 2 | GILD | Gilead Sciences, Inc. | 13.12% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 8.13% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 6.76% |
| 5 | MRNA | Moderna, Inc. | 6.52% |
| 6 | NTRA | Natera, Inc. | 5.70% |
| 7 | IQV | IQVIA Holdings Inc. | 5.16% |
| 8 | RVMD | Revolution Medicines, Inc. | 4.77% |
| 9 | ARGX | argenx SE | 4.59% |
| 10 | ILMN | Illumina, Inc. | 3.80% |
| 11 | BIIB | Biogen Inc. | 3.16% |
| 12 | ONC | BeOne Medicines AG | 3.00% |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.69% |
| 14 | INSM | Insmed Incorporated | 2.67% |
| 15 | INCY | Incyte Corporation | 2.41% |
| 16 | UTHR | United Therapeutics Corporation | 2.23% |
| 17 | BNTX | BioNTech SE | 1.77% |
| 18 | NBIX | Neurocrine Biosciences, Inc. | 1.61% |
| 19 | CRL | Charles River Laboratories International, Inc. | 1.60% |
| 20 | ICLR | ICON Public Limited Company | 1.60% |
| 21 | TECH | Bio-Techne Corporation | 1.36% |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 1.31% |
| 23 | TEM | Tempus AI, Inc. | 1.17% |
| 24 | QGEN | Qiagen N.V. | 1.04% |
| 25 | n/a | Us Dollar | 0.09% |
As of Sep 18, 2026